Results 231 to 240 of about 89,996 (262)
Some of the next articles are maybe not open access.
Fat paradox of steatohepatitis
Journal of Gastroenterology and Hepatology, 2008AbstractAlcoholic and non‐alcoholic steatohepatitis (ASH and NASH) constitute two major types of chronic liver disease with worldwide prevalence and are histologically indistinguishable with shared pathogenetic mechanisms. More importantly, they have synergistic interactions for liver pathology. Comparative studies on ASH and NASH have been hampered by
Hidekazu, Tsukamoto +4 more
openaire +2 more sources
Inflammation and fibrogenesis in steatohepatitis
Journal of Gastroenterology, 2012Nonalcoholic fatty liver disease consists of a range of disorders characterized by excess accumulation of triglyceride within the liver. Whereas simple steatosis is clinically benign, nonalcoholic steatohepatitis (NASH) often progresses to cirrhosis.
Hideki, Fujii, Norifumi, Kawada
openaire +2 more sources
Fibrogenesis in nonalcoholic steatohepatitis
Expert Review of Gastroenterology & Hepatology, 2011Nonalcoholic steatohepatitis includes a wide spectrum of liver injury, ranging from simple inflammation to fibrosis and cirrhosis. Whereas simple steatosis has a benign clinical course, steatohepatitis is a recognized cause of progressive liver fibrosis and can develop, in some circumstances, into cirrhosis.
De Minicis +2 more
openaire +3 more sources
Pathology of nonalcoholic steatohepatitis
Hepatology Research, 2005To date, histologic evaluation, most commonly in the form of liver biopsy, remains the gold standard in evaluation of nonalcoholic fatty liver disease (NAFLD). Histologic evaluation was fundamental to the initial studies that introduced and defined the concept of fatty liver as a liver disease.
openaire +2 more sources
Alcoholic and nonalcoholic steatohepatitis
Clinics in Liver Disease, 2002The constellation of histopathologic lesions that characterize alcoholic and nonalcoholic steatohepatitis has been well described and has served as the basis for clinical diagnosis, natural history studies, and experimental models for analyses of etiopathogenesis.
openaire +2 more sources
[Adipocitokines and nonalcoholic steatohepatitis].
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2010Nonalcoholic steatohepatitis is one of the most common liver diseases. It is part of the nonalcoholic fatty liver disease, which ranges from simple hepatic steatosis to necroinflammation and fibrosis of various degrees, so that many patients can evolve towards advanced liver disfunction and even cirrhosis. Insulin resistance is the main factor involved
Cristina, Lăcătuşu +4 more
openaire +2 more sources
Therapeutic pipeline in nonalcoholic steatohepatitis
Nature Reviews Gastroenterology and Hepatology, 2021, Naim Alkhouri, Raj Vuppalanchi
exaly
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Cell Metabolism, 2023Zhao Sihai +2 more
exaly
The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression
Nature Communications, 2021, Liwei Xie, Yujun Zhao
exaly